publication date: Sep. 7, 2018

Mendelsohn retires from MD Anderson

By Paul Goldberg

John Mendelsohn has retired from MD Anderson Cancer Center, which he served as president for 15 years, from 1996 to 2011.

Mendelsohn’s retirement went in effect on Aug. 31, his 82nd birthday.

Prior to retirement, the UT System Board of Regents named Mendelsohn MD Anderson president emeritus. He will be stepping down from his position as director of the Khalifa Institute for Personalized Cancer Therapy.

“It is bittersweet to step away, but it is the right decision for my family and me,” Mendelsohn, who has been ill, wrote to the faculty and staff on Aug. 21. The announcements, by Mendelsohn and MD Anderson President Peter Pisters do not refer to his health.

The Houston Chronicle last month made public the fact that Mendelsohn has glioblastoma.

The text of Mendelsohn’s email to the MD Anderson colleagues follows:


From: Mendelsohn, John

Subject: Re: My Plans

Date: Tuesday, August 21, 2018 2:02:05 PM

Dear Colleagues:

Prior to a broad announcement, I wanted personally to share with you my decision to retire on August 31.

My time at MD Anderson has been the capstone of my career. It is bittersweet to step away, but it is the right decision for my family and me.

What an incredible opportunity I was given in 1996 to become this great institution’s third full-time president. I continue to be inspired by the people who dedicate themselves to our mission, and by our patients and their families.

As president, I had the privilege of … Continue reading Mendelsohn retires from MD Anderson

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.